These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30445763)

  • 1. Imidazo[1,2-
    Chouchou A; Patinote C; Cuq P; Bonnet PA; Deleuze-Masquéfa C
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30445763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
    Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitative estimation of new imiqualine leads with potent anticancer activities in rat and mouse plasma. Application to a pharmacokinetic study in mice.
    Chouchou A; Marion B; Enjalbal C; Roques C; Cuq P; Bonnet PA; Bressolle-Gomeni FMM; Deleuze-Masquéfa C
    J Pharm Biomed Anal; 2018 Jan; 148():369-379. PubMed ID: 29111492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazo[1,2-a]quinoxalines for melanoma treatment with original mechanism of action.
    Patinote C; Deleuze-Masquéfa C; Kaddour KH; Vincent LA; Larive R; Zghaib Z; Guichou JF; Assaf MD; Cuq P; Bonnet PA
    Eur J Med Chem; 2021 Feb; 212():113031. PubMed ID: 33309473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
    Moarbess G; Deleuze-Masquefa C; Bonnard V; Gayraud-Paniagua S; Vidal JR; Bressolle F; Pinguet F; Bonnet PA
    Bioorg Med Chem; 2008 Jul; 16(13):6601-10. PubMed ID: 18513976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [1,2,4]triazolo[4,3-
    Patinote C; Raevens S; Baumann A; Pellegrin E; Bonnet PA; Deleuze-Masquéfa C
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure-activity relationships.
    Zghaib Z; Guichou JF; Vappiani J; Bec N; Hadj-Kaddour K; Vincent LA; Paniagua-Gayraud S; Larroque C; Moarbess G; Cuq P; Kassab I; Deleuze-Masquéfa C; Diab-Assaf M; Bonnet PA
    Bioorg Med Chem; 2016 Jun; 24(11):2433-2440. PubMed ID: 27094151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile synthesis of C6-substituted benz[4,5]imidazo[1,2-a]quinoxaline derivatives and their anticancer evaluation.
    Singh R; Kumar R; Pandrala M; Kaur P; Gupta S; Tailor D; Malhotra SV; Salunke DB
    Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000393. PubMed ID: 33749032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
    Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents.
    Rodrigues FA; Bomfim Ida S; Cavalcanti BC; Pessoa Cdo Ó; Wardell JL; Wardell SM; Pinheiro AC; Kaiser CR; Nogueira TC; Low JN; Gomes LR; de Souza MV
    Bioorg Med Chem Lett; 2014 Feb; 24(3):934-9. PubMed ID: 24398294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives.
    Hajri M; Esteve MA; Khoumeri O; Abderrahim R; Terme T; Montana M; Vanelle P
    Eur J Med Chem; 2016 Nov; 124():959-966. PubMed ID: 27770736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphonamido-quinoxalines: search for anticancer agent.
    Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
    Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma.
    Khier S; Deleuze-Masquéfa C; Moarbess G; Gattacceca F; Margout D; Solassol I; Cooper JF; Pinguet F; Bonnet PA; Bressolle FM
    Eur J Pharm Sci; 2010 Jan; 39(1-3):23-9. PubMed ID: 19854270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
    Abbas HA; Al-Marhabi AR; Eissa SI; Ammar YA
    Bioorg Med Chem; 2015 Oct; 23(20):6560-72. PubMed ID: 26420384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and pharmacokinetics of EAPB0203 and EAPB0503, two imidazoquinoxaline compounds previously shown to have antitumoral activity on melanoma and T-lymphomas.
    Khier S; Gattacceca F; El Messaoudi S; Lafaille F; Deleuze-Masquéfa C; Bompart J; Cooper JF; Solassol I; Pinguet F; Bonnet PA; Bressolle FM
    Drug Metab Dispos; 2010 Oct; 38(10):1836-47. PubMed ID: 20660102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors.
    Ibrahim MK; Taghour MS; Metwaly AM; Belal A; Mehany ABM; Elhendawy MA; Radwan MM; Yassin AM; El-Deeb NM; Hafez EE; ElSohly MA; Eissa IH
    Eur J Med Chem; 2018 Jul; 155():117-134. PubMed ID: 29885574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxicity of 2-methyl-4, 9-dihydro-1-substituted-1H-imidazo[4,5-g]quinoxaline-4,9-diones and 2,3-disubstituted-5,10-pyrazino[2,3-g]quinoxalinediones.
    Yoo HW; Suh ME; Park SW
    J Med Chem; 1998 Nov; 41(24):4716-22. PubMed ID: 9822542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro antitumor activity of new quinoxaline derivatives.
    Corona P; Carta A; Loriga M; Vitale G; Paglietti G
    Eur J Med Chem; 2009 Apr; 44(4):1579-91. PubMed ID: 18774202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.